Kiniksa Pharmaceuticals International, plc
Kiniksa Pharmaceuticals International develops biologic therapies for cardiovascular indications and diseases with unmet need.
424B3Sep 11Latest SEC filing
Jul 28Latest story
July 2026
Kiniksa Pharmaceuticals International develops biologic therapies for cardiovascular indications and diseases with unmet need.